Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunotherapy and Oncogenic Pathways: The PTEN Connection.

Cancer discovery - 1 Feb 2016

Rizvi Naiyer A, Chan Timothy A

Abstract excerpt

Peng and colleagues describe the effects of PTEN inactivation on antitumor immunity and response to immune checkpoint blockade in melanoma. These results shed light on the intricate interplay between oncogenic pathways and antitumor immune response.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Immunotherapy
Share to Melanoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasm Metastasis

Share to PTEN Phosphohydrolase

Share to Signal Transduction

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 26851183
DOI: 10.1158/2159-8290.CD-15-1501
PMCID: PMC4746001

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunotherapy and Oncogenic Pathways: The PTEN Connection.PMID 26851183Read ↗

Emerging role of PTEN loss in evasion of the immune response to tumours.Semantic proximity Read ↗

The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy ResponseSemantic proximity Read ↗

Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old StorySemantic proximity Read ↗

The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy.Semantic proximity Read ↗

Epistatic Oncogenic Interactions Determine Cancer Susceptibility to Immunotherapy.Semantic proximity Read ↗

Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer.Semantic proximity Read ↗

Immunomodulating property of MAPK inhibitors: from translational knowledge to clinical implementation.Semantic proximity Read ↗

Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.Semantic proximity Read ↗

Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in CancerSemantic proximity Read ↗

Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?Semantic proximity Read ↗

PTEN Mutations Trigger Resistance to ImmunotherapySemantic proximity Read ↗

Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.